41 – 50 of 134
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
- Contribution to journal › Scientific review
-
Mark
PDGF-B Is Required for Development of the Glymphatic System
- Contribution to journal › Article
-
Mark
Towards a unified protocol for handling of CSF before β-amyloid measurements
- Contribution to journal › Article
-
Mark
α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson’s disease patients
(2019) In Proceedings of the National Academy of Sciences of the United States of America 116(30). p.15226-15235
- Contribution to journal › Article
-
Mark
Assessment of Brain Injury and Brain Volumes after Posthemorrhagic Ventricular Dilatation : A Nested Substudy of the Randomized Controlled ELVIS Trial
- Contribution to journal › Article
-
Mark
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
- Contribution to journal › Article
- 2018
-
Mark
Aquaporin-4-dependent glymphatic solute transport in the rodent brain
- Contribution to journal › Article
-
Mark
Investigation of cerebrospinal fluid flow in the cerebral aqueduct using high-resolution phase contrast measurements at 7T MRI
- Contribution to journal › Article
-
Mark
A critical evaluation of wet biomarkers for huntington's disease : Current status and ways forward
- Contribution to journal › Scientific review
-
Mark
Update on biomarkers for amyloid pathology in Alzheimer's disease
- Contribution to journal › Scientific review
